Learning Objectives:

1) Acquire an understanding of the pre-symptomatic stage of ALS, with insights from the pre-symptomatic stages of other neurodegenerative disorders;

2) Recognize the existence of mild motor impairment (MMI) as a prodromal clinical state in ALS;

3) Acquire an understanding of ongoing efforts to determine whether some genetic forms of ALS might be prevented

Session date: 
11/10/2023 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Michael Benatar